Ruminococcus spp. as Next Generation Probiotics

Background Ruminococcus spp. for Health Services and Products Features FAQs Resources

Introduction of Ruminococcus spp.

Creative Biolabs can help you advance your live biotherapeutic products (LBP) research & development with our well-established platform. You can count on our skilled and passionate workforce to find the most suitable path. We can make your LBP journey easier.

Introduction of Ruminococcus spp.

Ruminococcus is an important group of intestinal mutualistic bacteria, which degrade complex polysaccharides and convert them into various nutrients of the host. Ruminococcus is a bacterium in the class Clostridia. The genus Ruminococcus is defined as strictly-anaerobic, Gram-positive, non-motile cocci that do not produce endospores and require fermentable carbohydrates for growth. One or more species in this genus are found in significant numbers in the human gut microbiota. Most species of Ruminococcus are important and necessary for our digestive function. Next-generation sequencing has further shown that they are widely distributed in multiple animal hosts. The ruminococcus is now recognized as an important contributor to the intestinal ecosystem. Members of the genus Ruminococcus also have great application potential in biotechnology.

The best studied of the Lachnospiraceae is Ruminococcus gnavus. This species is also a member of the core gut microbiota. The Ruminococcus gnavus administration may modulate the Th2-related allergic inflammation in atopic dermatitis (AD) by inducing changes in SCFA-related and Treg-mediated immune pathways in the gut.

Hydrogen-producing Ruminococcus albus is more abundant in healthy individuals than in patients with Crohn’s disease and shows probiotic effects. Heat-killed Ruminococcus albus can inhibit oxidative stress-mediated neuronal cell damage and produce the neuroprotective effect.

Health Benefits of Ruminococcus spp.

The dominant commensal symbiont bacteria that produce SCFAs are Akkermansia muciniphilia, Prevotella spp., Ruminococcus spp., Coprococcus spp., Faecalibacterium prausnitzii, Eubacterium rectale, and Roseburia. The Ruminococcus bacteria in our gut microbiomes play a major role in helping us digest resistant starches. The slow digestion of these particular carbohydrates by Ruminococcus has been linked to many health benefits such as reversing infectious diarrhea and reducing the risk of diabetes and colon cancer. Members of Clostridium clusters XIVa and IV (e.g., Dorea spp., Lachnospiraceae, Ruminococcus spp., Faecalibacterium spp., and Roseburia spp.) are consistently depleted in people with IBD and acute colitis, suggesting that these organisms are important in maintaining intestinal homeostasis. Most normal-weight children have a gut bacterial community dominated by Ruminococcus spp., while most obese children had a community dominated by Prevotella spp.

Metabolism of resistant starch, a prebiotic, to butyrate and its known effects on the colon. Fig.1 Metabolism of resistant starch, a prebiotic, to butyrate and its known effects on the colon.1

Services and products about Ruminococcus spp. at Creative Biolabs

  • Services

We provide Microbial Isolation and Screening, Microbial Identification, Microbial Purifying, and other analytical development services for Ruminococcus spp.

  • Products

The strains with different preservation numbers in Ruminococcus spp. can be supplied. In addition, we can customize the production of strain culture supernatant and lyophilized powder containing certain CFU according to the customer's research.

CAT Product Name Product Overview Price
LBSX-0522-GF68 Ruminococcus gnavus; 29149 Ruminococcus gnavus was isolated from human faeces. Inquiry
LBSX-0522-GF69 Ruminococcus gnavus; 43222 Ruminococcus gnavus was isolated from human blood. Inquiry
LBSX-0522-GF75 Ruminococcus gauvreauii Ruminococcus gauvreauii was isolated from human faeces. Inquiry
LBSX-0522-GF76 Ruminococcus albus; 27210 Ruminococcus albus was isolated from bovine rumen. Inquiry
LBSX-0522-GF77 Ruminococcus champanelensis Ruminococcus champanelensis was isolated from human faeces. Inquiry
LBSX-0522-GF78 Ruminococcus obeum; 25238 Ruminococcus obeum is a species of anaerobic, gram-positive bacteria. It was isolated from human faeces. Inquiry
LBGF-0722-GF39 Ruminococcus sp.; 102803 Ruminococcus sp. is a Gram-positive gut microbe. It was isolated from human faeces. Inquiry

Key Features of Creative Biolabs’ Services

  • Cost effective and comprehensive
  • Fast turnaround time
  • Guaranteed results

The development and validation of probiotics and LBP are complex and require carefully designed studies. Creative Biolabs has the expertise to optimize each stage. Contact us to learn more about our LBP development service.


What specific characteristics of Ruminococcus spp. make it suitable for probiotic development?

Ruminococcus spp. are recognized for their ability to degrade complex carbohydrates and produce short-chain fatty acids (SCFAs), notably butyrate. These metabolic activities are crucial for maintaining gut health and potentially preventing diseases such as diabetes and colon cancer.

Can Ruminococcus spp. be customized for specific research needs?

Yes, Ruminococcus spp. can be customized according to specific research needs. Creative Biolabs offers services to alter growth media, genetic makeup, or metabolite profiles of the strains, enabling researchers to explore their effects under varied experimental conditions.

What types of safety and efficacy tests are performed on Ruminococcus spp. at Creative Biolabs?

To assess the safety and potential probiotic properties of Ruminococcus spp., Creative Biolabs conducts a range of tests including antimicrobial assays, biofilm assays, and survival assays under simulated gastrointestinal conditions. These tests help establish the safety and functional efficacy of the strains.

How does Creative Biolabs support the scale-up production of Ruminococcus spp.?

Creative Biolabs offers comprehensive scale-up production services from lab-scale cultivation to large-scale production, ensuring that sufficient quantities of Ruminococcus spp. are available for extensive scientific research and pre-clinical trials. This supports the seamless transition from discovery to application.



  1. Chang, A.E.; et al. Targeting the gut microbiome to mitigate immunotherapy-induced colitis in cancer. Trends in Cancer. 2021, 7(7): 583-593.

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Contact us

Live Biotherapeutic

Contact us

Copyright © 2024 Creative Biolabs. All Rights Reserved.

Inquiry Basket